SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001437749-23-002015
Filing Date
2023-01-30
Accepted
2023-01-30 09:17:14
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 424B4 pbla20230127_424b4.htm 424B4 1782345
2 pbla20230127_424b4img001.jpg GRAPHIC 5073
3 pbla20230127_424b4img002.jpg GRAPHIC 33791
4 pbla20230127_424b4img003.jpg GRAPHIC 25312
5 pbla20230127_424b4img004.jpg GRAPHIC 17907
  Complete submission text file 0001437749-23-002015.txt   1897192
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-268854 | Film No.: 23565473
SIC: 2834 Pharmaceutical Preparations